George L. Sing, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 11,300 shares at $650.00 ($7.3M) on 2020-07-07, disclosed to the SEC on 2020-07-08.
Open-market sale of $7.3M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $650.00 | 500 | $325K | 4.4% |
| 2 | $650.00 | 1,500 | $975K | 13.3% |
| 3 | $650.00 | 7,500 | $4.9M | 66.4% |
| 4 | $650.32 | 800 | $520K | 7.1% |
| 5 | $650.32 | 800 | $520K | 7.1% |
| 6 | $651.09 | 200 |
| $130K |
| 1.8% |
| Total | $650.06 avg | 11,300 | $7.3M | 100% |
| Filing → |
| REGN | SELL | 2024-02-12 | $950K | — | Filing → |
| REGN | SELL | 2022-03-01 | $2.5M | — | Filing → |
| REGN | SELL | 2021-11-23 | $2.0M | — | Filing → |